Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

168
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
168
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

43.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.0K
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

208
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
208
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

308
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
308

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Prospective Study of Steerable Ureteroscopic Renal Evacuation Using the Second-Generation CVAC® Aspiration System: Results from the CLEARANCE Study.

Journal of endourology·2026
Same author

Residual Stone Volume Predicts Health Care Consumption and Stone Events: Analysis of Two-Year Results of the ASPIRE Study.

Journal of endourology·2026
Same author

Highlighting the 2025 AUA Nephrolithiasis Guidelines.

The Journal of urology·2026
Same author

Thermal injury and treatment efficiency during thulium fiber laser lithotripsy: insights from an in vivo porcine model.

World journal of urology·2026
Same author

Nanofluid-Enhanced Laser Lithotripsy Using Conducting Polymer Nanoparticles.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Local Delivery of Non-opioid Analgesic Microparticles to Modulate Post-surgical Pain.

Pharmaceutical research·2025

Related Experiment Video

Updated: May 4, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.1K

Antiretropulsion devices.

Fernando J Cabrera1, Glenn M Preminger, Michael E Lipkin

  • 1Comprehensive Kidney Stone Center Duke University Medical Center Durham, North Carolina, USA.

Current Opinion in Urology
|January 15, 2014
PubMed
Summary
This summary is machine-generated.

Antiretropulsion devices effectively prevent ureteral stone migration during ureteroscopic lithotripsy, improving stone-free rates and reducing patient morbidity. These devices are also cost-effective, offering significant benefits in stone treatment.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.6K

Related Experiment Videos

Last Updated: May 4, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.1K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.6K

Area of Science:

  • Urology
  • Medical Devices
  • Endourology

Background:

  • Ureteral stone migration during treatment is a common challenge.
  • This migration increases healthcare costs and patient morbidity.
  • Antiretropulsion devices are designed to mitigate stone displacement.

Purpose of the Study:

  • To review the efficacy and safety of antiretropulsion devices in preventing ureteral stone migration.
  • To assess the impact of these devices on treatment outcomes and cost-effectiveness.

Main Methods:

  • Review of current literature on antiretropulsion devices used in ureteroscopic lithotripsy.
  • Analysis of device performance, complication rates, and economic impact.

Main Results:

  • Antiretropulsion devices efficiently prevent stone migration during ureteroscopic lithotripsy.
  • Available devices offer varied advantages and disadvantages.
  • Newer devices aim to enhance stone prevention and maintain ureteral access.
  • These devices demonstrate cost-effectiveness in preventing stone migration.

Conclusions:

  • Antiretropulsion devices are safe and effective for ureteroscopic procedures.
  • Their use improves stone-free rates and reduces patient morbidity.
  • Studies confirm the cost-effectiveness of employing these devices in stone management.